SEO URLwww.firestrike.ai/deals/teli-pharmaceuticals-telomir-pharmaceuticals-acquisition-2026

acquisitionAnnounced · Apr 24, 2026PharmaceuticalsSource · Unverified ReportsArticle · Factual

TELI Pharmaceuticals · Telomir Pharmaceuticals

Telomir Pharmaceuticals acquires TELI Pharmaceuticals

David Najork · Founding Software Engineer

Published Apr 25, 2026 · Updated Apr 25, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$5M

Target

TELI Pharmaceuticals

Acquirer

Telomir Pharmaceuticals

Full Acquisition

Status

Pending

Telomir Pharmaceuticals agreed to acquire TELI Pharmaceuticals. Reported deal value: $5M. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-04-24. Figures and status may change as filings and press coverage update.

ACCESS Newswire Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 ACCESS Newswire Apr 24, 2026 32 mins ago Transaction establishes global ownership rights of lead program and includes initial capital funding with additional optional milestone-based capital support aligned with key clinical milestones

Deal timeline

Announced

Apr 24, 2026 · corsicanadailysun.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Pharmaceuticals with a reported deal value of $5M. Figures and status may change as sources update.

Sources: corsicanadailysun.com · Primary article · FireStrike proprietary index